CSL Limited share price ASX CSL

CSL Limited (CSL)

CSL Limited develops manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines infection and pain medicine skin disorder remedies antivenoms anticoagulants and immunoglobulins.

Our Commentary: Updated 13th February 2013

CSL has released its first-half results, with its profit of US$632 million beating market expectations and weighing in 25% higher than a year before.

The result was driven by royalties from its drug to prevent cervical cancer and increased market share after its competitor closed down part of its operations. Stripping out the effect of currency rates, CSL expects profit to rise by around 20% and EPS to grow by about 24% in FY13.

CSL announced an unfranked interim dividend of 50 cents per share—higher than the prior corresponding period’s 37.57 cents—to be payable on 5 April 2013.

free trial
Shares Graph
Why Australian Stock Report?
  • We'll show you which stocks to BUY, SELL & WHY
  • How to make money in a falling market
  • How to maximise your self managed superannuation
  • We'll educate you on how to trade like a professional
  • Access to a team of expert investment analysts
  • Comprehensive Member Support hotline
There is strength in numbers - meet the team
geoff safer

Geoff Saffer
CFA

Head of Corporate Research

chris conway

Chris Conway
LLB BEc Dip FS(FP) Dip TA(ATAA) CFTe(IFTA)

Head of Research and Trading


kel butcher

Kel Butcher

Senior Trader

benny sada

Benny Sada
BEc(Hons) MAppFin(FINSIA)

Senior Equity Analyst


adam halantas

Adam Halantas
BBus (FRM) MAppFin (FINSIA)

Research Analyst

carl capolingua

Carl Capolingua
BEc Grad Dip FP(FINSIA)

Head of Education


Australian Stock Report is located at: Level 4/419-425 Collins Street, Melbourne VIC 3000.
In providing your personal details and registering for a free trial report, you consent to Australian Stock Report communicating with you via the contact details provided by you, for the purpose of discussing the sale of subscriptions to the Australian Stock Report with you.
You acknowledge and consent that in the event that you have provided false information or misleading contact information for the purposes of the free trial registration, that ASR can terminate your free trial immediately.
Is now a good time to buy CSL Limited shares?
asx-share-price Sign up for a FREE 7 day trial

To start your Free 7 day trial please complete your details below

* required fields

IMPORTANT: an activation code will be sent via SMS, please enter your preferred mobile number